mTOR Pathway and mTOR Inhibitors in Cancer Therapy
mTOR Pathway and mTOR Inhibitors in Cancer Therapy provides an up-to-date survey of the rapidly advancing field of cancer therapy. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer trea...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Totowa, NJ :
Humana Press : Imprint: Humana Press,
2010.
|
Σειρά: | Cancer Drug Discovery and Development
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- mTORC1: A Signaling Integration Node Involved in Cell Growth
- The Regulation of the IGF-1/mTOR Pathway by the p53 Tumor Suppressor Gene Functions
- mTOR Signaling in Angiogenesis
- mTORC1 Signaling and Hypoxia
- mTOR Signaling in Glioblastoma: Lessons Learned from Bench to Bedside
- mTOR and Cancer Therapy: General Principles
- mTOR and Cancer Therapy: Clinical Development and Novel Prospects
- Drug Combinations as a Therapeutic Approach for mTORC1 Inhibitors in Human Cancer
- Downstream Targets of mTORC1
- Downstream of mTOR: Translational Control of Cancer
- Genome-Wide Analysis of Translational Control
- Translational Control of Cancer: Implications for Targeted Therapy
- Downstream from mTOR: Therapeutic Approaches to Targeting the eIF4F Translation Initiation Complex.